Position in CUE
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$8,912
-$3,608 QoQ
Shares Held
38,750
-5.6% QoQ
Ownership
0.958%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 53 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sigma Planning Corp holds $10,800,162 across 16 Biotechnology names. CUE ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
7,297 | $1,669,042 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,012 | $1,554,551 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
20,592 | $1,330,860 | |
| 4 | SRPT |
Sarepta Therapeutics, Inc.
|
61,060 | $1,328,665 | |
| 5 | MRNA |
Moderna, Inc.
|
25,705 | $1,305,814 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
4,500 | $898,425 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,062 | $474,225 | |
| 8 | RNTX |
Rein Therapeutics, Inc.
|
348,677 | $453,280 |
All Filings in CUE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,912 | 38,750 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $12,520 | 41,050 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $38,322 | 53,300 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $37,851 | 55,500 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $297,222 | 326,260 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $487,420 | 447,175 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $303,803 | 401,325 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $329,877 | 266,030 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $483,849 | 256,005 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $287,430 | 108,875 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $562,821 | 244,705 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $822,345 | 225,300 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $788,573 | 220,889 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $549,291 | 192,734 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $420,185 | 188,424 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $416,093 | 167,106 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $633,072 | 129,728 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $971,449 | 85,893 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,227,420 | 84,243 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $951,816 | 81,701 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $891,673 | 73,088 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $895,415 | 71,576 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $900,336 | 59,823 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,300,966 | 53,079 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $940,016 | 66,245 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||